Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes

Insights

High oxygen exposure increases lung chemoattractant activity, drawing in polymorphonuclear leukocytes (PMN). This influx correlates with lung injury and mortality in rats, suggesting PMN involvement in oxygen toxicity.

Area of Science:

  • Pulmonary Medicine
  • Toxicology
  • Cellular Biology

Background:

  • Pulmonary oxygen toxicity pathogenesis remains unclear.
  • Increased polymorphonuclear leukocytes (PMN) and endothelial damage suggest PMN's role in hyperoxia-induced lung injury.

Purpose of the Study:

  • To investigate the mechanism behind PMN influx during hyperoxia.
  • To measure PMN chemoattractant activity in rat lung lavages after oxygen exposure.

Main Methods:

  • Rats were exposed to hyperoxia (>95% oxygen) for varying durations.
  • Lung lavage fluid was analyzed for chemoattractant activity for PMN.
  • PMN counts in alveolar lavages were quantified.

Main Results:

  • A significant increase in lung lavage chemoattractant activity was observed after 66 hours of hyperoxia.
  • This increase correlated with a 7-fold rise in PMN in alveolar lavages.
  • A high mortality rate (71%) occurred in rats exposed to hyperoxia for 66 hours.

Conclusions:

  • A temporal relationship exists between chemoattractant generation, PMN influx, and mortality.
  • These findings support the hypothesis that PMN contribute to the pathogenesis of pulmonary oxygen toxicity.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...